Pharma Corporate VC Funding Infographic
The corporate VC arms of the top 10 pharmaceutical companies by sales have invested $4.7B since 2014 in 147 rounds of financing, mostly in A and B rounds and mostly in the US. Most investments are in companies with small molecules in discovery through Phase 1.
This website uses cookies to ensure you get the best experience on our website. Learn more